Eperisone Analogs, Rescuers of MiaB Defects As a Prokaryotic Homologue of CDKAL1, Suppress Blood Glucose Elevation in Rats
Clicks: 23
ID: 281177
2025
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.7
/100
9 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Cdk5 regulatory associated protein 1-like 1 () is one of the most reliable risk genes for type 2 diabetes mellitus (T2DM). Because controls glucose-induced insulin secretion by K channel responsiveness and faithful decoding of Lys codons to prevent mistranslation in pancreatic β-cells, a rescuer of defects is expected as a new antidiabetes drug. We found that eperisone analogs effectively rescued mistranslation in a -deficient dual-luciferase reporter gene system ( is a prokaryotic homologue of eukaryotic ). Among them, compounds and demonstrated significant antihyperglycemic efficacy in an oral glucose tolerance test by subcutaneous administration in Wister rats, along with a significant enhancement of insulin secretion in the MIN6 insulinoma cell line without cytotoxicity. These results indicate that could be a viable molecular target for a new anti-T2DM medication.
| Reference Key |
tejima2025eperisoneacs
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tejima, M. |
| Journal | ACS medicinal chemistry letters |
| Year | 2025 |
| DOI |
10.1021/acsmedchemlett.4c00560
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.